Liquidia Technologies
Latest round
- Series D
Last raised
- Feb 2018
Total raised
- $86M
Investors
- 12
About Liquidia Technologies
Based in North Carolina, US, and founded in 2004 by CEO Roger jeffs, Liquidia Technologies Inc. operates as a biopharmaceutical company that utilizes PRINT technology that helps in developing engineered particle-based vaccines and therapeutics. In January 2024, Liquidia Technologies Inc. received USD 25 million from Healthcare Royalty Partners. Liquidia Technologies Inc. developed a product known as Yutrepia inhalation powder, which is designed for the treatment of PAH and pulmonary arterial hypertension associated with interstitial lung disease (PH-ILD). It leverages print technology to improve lung deposition and minimize upper airway deposition, ensuring better patient outcomes. The company is also involved in the commercialization of generic Treprostinil Injection for the treatment of rare diseases, in partnership with Sandoz. In addition, the firm’s research and development developed therapies through its print technology, which allows for precise control over the size, shape, and chemical composition of drug particles.
Who invested in Liquidia Technologies
12 investors across 8 rounds
See all investors in Liquidia Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Feb 2, 2018
Amount
$26M
Investors
Series D
Jul 2, 2012
Amount
$3.8M
Investors
Series D
Mar 3, 2011
Amount
$10M
Investors
Series C
Apr 20, 2010
Amount
$5M
Investors
Series C
Jan 21, 2010
Amount
$13M
Investors
Series C
Jul 1, 2009
Amount
$7M
Investors
Series B
Mar 2, 2007
Amount
$16M
Investors
Series A
May 23, 2006
Amount
$6M
Investors
Questions about Liquidia Technologies
Who invested in Liquidia Technologies?
Liquidia Technologies has 12 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Liquidia Technologies raised?
Liquidia Technologies has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did Liquidia Technologies last raise money?
Liquidia Technologies's most recent round on record is a Series D, in Feb 2018.
What does Liquidia Technologies do?
Based in North Carolina, US, and founded in 2004 by CEO Roger jeffs, Liquidia Technologies Inc.
Where is Liquidia Technologies headquartered?
Liquidia Technologies is headquartered in Morrisville, US.
Which VCs invest in companies like Liquidia Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Liquidia Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Liquidia Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.